Metropolitan Life Insurance Company (MetLife)’s Kodiak Sciences KOD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-699
Closed -$3.68K 1129
2024
Q1
$3.68K Buy
+699
New +$3.42K ﹤0.01% 2267
2023
Q3
Sell
-1,844
Closed -$12.7K 2420
2023
Q2
$12.7K Hold
1,844
﹤0.01% 2167
2023
Q1
$11.4K Sell
1,844
-198
-10% -$1.39K ﹤0.01% 2106
2022
Q4
$14.6K Hold
2,042
﹤0.01% 2143
2022
Q3
$15.8K Hold
2,042
﹤0.01% 2132
2022
Q2
$15.6K Hold
2,042
﹤0.01% 2156
2022
Q1
$15.8K Sell
2,042
-6,680
-77% -$261K ﹤0.01% 2193
2021
Q4
$739K Sell
8,722
-532
-6% -$54.1K 0.01% 1164
2021
Q3
$888K Hold
9,254
0.01% 1054
2021
Q2
$861K Buy
9,254
+615
+7% +$59K 0.01% 1132
2021
Q1
$980K Sell
8,639
-296
-3% -$40.4K 0.01% 937
2020
Q4
$1.31M Buy
8,935
+380
+4% +$42.4K 0.02% 702
2020
Q3
$507K Hold
8,555
0.01% 1211
2020
Q2
$463K Hold
8,555
0.01% 1270
2020
Q1
$408K Buy
8,555
+1,157
+16% +$69.4K 0.01% 1174
2019
Q4
$532K Sell
7,398
-1,709
-19% -$62.2K 0.01% 1288
2019
Q3
$131K Buy
9,107
+7,121
+359% +$93K ﹤0.01% 2153
2019
Q2
$23.2K Buy
+1,986
New +$17.7K ﹤0.01% 2589

Other funds holding KOD

Metropolitan Life Insurance Company (MetLife)'s KOD Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Kodiak Sciences (KOD) in Q2 2024, closing a stake of 699 shares — an estimated $3.68K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in KOD in Q2 2019 and held it in 18 quarters. The position peaked at $1.31M in Q4 2020. 106 funds tracked by Wall St. Rank hold KOD as of Q2 2024.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining Kodiak Sciences position as of Q2 2024 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 699 Kodiak Sciences shares in Q2 2024, an estimated $3.68K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in Kodiak Sciences in Q2 2019 and held it in 18 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s Kodiak Sciences position peaked at $1.31M in Q4 2020.
  • 106 funds tracked by Wall St. Rank held Kodiak Sciences as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.